Findings of European expert meeting on faster access to innovative medicines
The first steps have been taken towards new market authorisation and reimbursement procedures for innovative medicines. Over 100 experts from across Europe discussed the topic in Amsterdam at the invitation of the Minister of Health, Welfare and Sport, Edith Schippers.
Increasing availability of innovative medicines
More and more innovative medicines are becoming available. This is good news for the patients who need them. However, since these medicines are often intended for a small group of people, there is not always enough research data available. This means it takes longer to determine the efficacy, safety and added value of these drugs. And the longer that takes, the longer patients have to wait until they can obtain the new drugs.
Accelerating market authorisation
During the Dutch EU Presidency, Ms Schippers would like to speed up market authorisation procedures for new medicines. ‘Here in Europe we need to look at how we can get these medicines to patients who’ve been waiting for them as soon as possible, without any safety risks,’ said the minister. ‘This must go hand in hand with affordability. After all, what’s the point of authorising a medicine if it’s completely unaffordable? Innovative medicines require effective collaboration on market authorisation and reimbursement policies at an early stage. At present, there is insufficient cooperation between the authorities responsible for these at both national and international level.’
Three key questions
The experts looked at the various methods for accelerated or conditional market authorisation and ways for different countries and authorities to share research data with each other. They examined three questions. What products need to be made available more quickly? What conditions should we place on this? And what procedures need to be better aligned?
Broad agreement on urgency
The discussions revealed that the experts agree on the importance of taking joint action. A future-proof EU system will require both an updated market authorisation policy and new reimbursement methods. More effective collaboration between the authorities responsible for market authorisation and reimbursement is crucial to fast, affordable access to innovative medicines.
The findings of the conference will be addressed at the health council meeting in April, when health ministers from the 28 EU member states will discuss the EU’s policy on medicines.
Latest News from
EU clears way for the EU Digital COVID Certificate15/06/2021 09:25:00
The Presidents of the three EU institutions, the European Parliament, the Council of the EU and the European Commission yesterday attended the official signing ceremony for the Regulation on the EU Digital COVID Certificate, marking the end of the legislative process.
Council agrees on new rules for cross-border energy infrastructure14/06/2021 16:48:00
The Council recently (11 June 2021) reached a general approach on the revision of the Trans-European Networks for Energy (TEN-E) Regulation.
Council approves conclusions on an EU renovation wave14/06/2021 15:25:00
The Council recently (11 June 2021) approved conclusions on a renovation wave that repairs the economy now, and creates green buildings for the future.
Council approves EU-UK agreement on fishing opportunities14/06/2021 13:25:00
The Council recently (11 June 2021) approved the agreement between the European Union and the United Kingdom on fishing opportunities for 2021 and, for deep-sea stocks, for 2021 and 2022.
EU-U.S Joint statement on the humanitarian emergency in Tigray14/06/2021 09:25:00
EU-U.S Joint statement given recently (10 June 2021) on the humanitarian emergency in Tigray.
Talent Partnerships: Commission launches new initiative to address EU skills shortages and improve migration cooperation with partner countries11/06/2021 16:33:00
Today, the Commission is launching Talent Partnerships, a key initiative under the New Pact on Migration and Asylum that will help to address skills shortages in the European Union and to strengthen mutually-beneficial partnerships on migration with third countries.
Central America and Mexico: EU reaffirms support with €18.5 million in humanitarian and development aid11/06/2021 15:25:00
The EU yesterday announced at the 'Solidarity event for forcibly displaced persons and host communities in Central America and Mexico', that it will allocate €18.5 million in aid. Of this sum, €12 million represents humanitarian funding to Central America, and €6.5 million constitutes development assistance.
Council endorses new EU strategy on adaptation to climate change11/06/2021 14:38:00
The Council yesterday approved conclusions endorsing a new strategy that outlines a long-term vision for the EU to become a climate-resilient society that is fully adapted to the unavoidable impacts of climate change by 2050.
Child Labour: Statement by the European Commission and the High Representative on the World Day against Child Labour11/06/2021 13:25:00
Child Labour: Statement given by the European Commission and the High Representative on the World Day against Child Labour.
Education: EU increases its commitment to Global Partnership for Education with a pledge of €700 million for 2021-202711/06/2021 12:38:00
Ahead of the G7 Summit, President of the European Commission Ursula von der Leyen yesterday announced that the European Union is pledging €700 million for the Global Partnership for Education (GPE) to help transform education systems for more than one billion girls and boys in up to 90 countries and territories.